About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Psoriatic Arthritis Treatment Market Size, Share & Growth to 2033

Psoriatic Arthritis Treatment Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, DMARDs, Biologics, Others), By Type (Prescription, OTC), By Route of Administration (Injectable, Oral, Topical) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI55449DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Psoriatic Arthritis Treatment Market Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. U.S.
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. NSAIDs
          1. By Value
        3. DMARDs
          1. By Value
        4. Biologics
          1. By Value
        5. Others
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Injectable
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
    6. Canada
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. U.K.
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. NSAIDs
          1. By Value
        3. DMARDs
          1. By Value
        4. Biologics
          1. By Value
        5. Others
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Injectable
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. China
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. NSAIDs
          1. By Value
        3. DMARDs
          1. By Value
        4. Biologics
          1. By Value
        5. Others
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Injectable
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. UAE
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. NSAIDs
          1. By Value
        3. DMARDs
          1. By Value
        4. Biologics
          1. By Value
        5. Others
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Injectable
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. Brazil
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. NSAIDs
          1. By Value
        3. DMARDs
          1. By Value
        4. Biologics
          1. By Value
        5. Others
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Injectable
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Psoriatic Arthritis Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. AbbVie Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Amgen Inc.
    3. Bausch Health Companies Inc.
    4. Bristol-Myers Squibb Company
    5. Celgene Corporation
    6. Eli Lilly and Company
    7. Johnson & Johnson Services, Inc.
    8. Novartis International AG
    9. Pfizer, Inc.
    10. UCB S.A.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Straits Research - Access Portal
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Get Free Access


We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.